Search research articles
Contact Us
Filters
Showing results (101-110 of 275) with videos related to
Page
of 28
Sort By:
Cancer Treatment Reviews
|
September 4, 2007
Assessment of tumor response in malignant pleural mesothelioma
Giovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
International Journal of Oncology
|
July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features
Alessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Journal of Bronchology & Interventional Pulmonology
|
July 1, 2024
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study
Fausto Leoncini, Giovanni Sotgiu, Alessandra Cancellieri, et al.
Clinical Lung Cancer
|
March 4, 2025
Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics
Rocco Trisolini, Valeria Cetoretta, Giovanni Sotgiu, et al.
Cancer Cytopathology
|
March 21, 2014
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment
Agnese Proietti, Greta Alì, Serena Pelliccioni, et al.
Cancer
|
February 21, 2008
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
Paolo A Zucali, Giovanni L Ceresoli, Isabella Garassino, et al.
Journal of Thoracic Disease
|
September 4, 2018
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group
Tao Jiang, Chunxia Su, Shengxiang Ren, et al.
Plos One
|
May 9, 2015
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study
Manolo D'Arcangelo, Matilde Todaro, Jessica Salvini, et al.
Clinical Lung Cancer
|
August 5, 2014
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series
Rita Chiari, Fiamma Buttitta, Daniela Iacono, et al.
Clinical Lung Cancer
|
June 14, 2014
Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study
Filippo de Marinis, Andrea Ardizzoni, Gabriella Fontanini, et al.
Page
of 28
Search research articles
Search
Showing results (101-110 of 275) with videos related to
Sort By:
Page
of 28
Cancer Treatment Reviews
|
September 4, 2007
Assessment of tumor response in malignant pleural mesothelioma
Giovanni L Ceresoli, Arturo Chiti, Paolo A Zucali, et al.
International Journal of Oncology
|
July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features
Alessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Journal of Bronchology & Interventional Pulmonology
|
July 1, 2024
Intrathoracic Lymph Node Microcalcifications are Associated With a High Prevalence of Malignancy and Anaplastic Lymphoma Kinase Rearrangement: The "Calce" Study
Fausto Leoncini, Giovanni Sotgiu, Alessandra Cancellieri, et al.
Clinical Lung Cancer
|
March 4, 2025
Supraclavicular Lymph Node Metastases in Advanced Lung Cancer: Prevalence and Analysis of Demographic, Clinical and Molecular Characteristics
Rocco Trisolini, Valeria Cetoretta, Giovanni Sotgiu, et al.
Cancer Cytopathology
|
March 21, 2014
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment
Agnese Proietti, Greta Alì, Serena Pelliccioni, et al.
Cancer
|
February 21, 2008
Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
Paolo A Zucali, Giovanni L Ceresoli, Isabella Garassino, et al.
Journal of Thoracic Disease
|
September 4, 2018
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group
Tao Jiang, Chunxia Su, Shengxiang Ren, et al.
Plos One
|
May 9, 2015
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study
Manolo D'Arcangelo, Matilde Todaro, Jessica Salvini, et al.
Clinical Lung Cancer
|
August 5, 2014
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series
Rita Chiari, Fiamma Buttitta, Daniela Iacono, et al.
Clinical Lung Cancer
|
June 14, 2014
Management of Italian patients with advanced non-small-cell lung cancer after second-line treatment: results of the longitudinal phase of the LIFE observational study
Filippo de Marinis, Andrea Ardizzoni, Gabriella Fontanini, et al.
Page
of 28